Published in J Acquir Immune Defic Syndr on December 01, 2015
Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions. Alcohol Clin Exp Res (2016) 0.83
Metabolic Complications and Glucose Metabolism in HIV Infection: A Review of the Evidence. Curr HIV/AIDS Rep (2016) 0.78
Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors. PLoS One (2016) 0.78
Alcohol use predicts elevation in inflammatory marker soluble CD14 in men living with HIV. AIDS Care (2016) 0.76
Tobacco and alcohol use among drug users receiving methadone maintenance treatment: a cross-sectional study in a rural prefecture of Yunnan Province, Southwest China. BMJ Open (2017) 0.75
Immune activation and neuroinflammation in alcohol use and HIV infection: evidence for shared mechanisms. Am J Drug Alcohol Abuse (2016) 0.75
Sex Differences in Tobacco Use Among Persons Living With HIV/AIDS: A Systematic Review and Meta-Analysis. J Acquir Immune Defic Syndr (2017) 0.75
Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med (2008) 13.72
Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab (2007) 9.77
Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis (2011) 7.41
Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ (2011) 6.11
Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med (2006) 5.49
Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis (2010) 5.35
Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ (1999) 4.14
Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis (2010) 3.79
The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol (2002) 3.71
Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS One (2012) 3.68
Arterial inflammation in patients with HIV. JAMA (2012) 3.42
Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr (2007) 3.24
Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. J Infect Dis (2011) 2.88
Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr (2006) 2.78
Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection. J Infect Dis (2012) 2.64
Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin Infect Dis (2007) 2.55
Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res (2005) 2.55
Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV? Clin Infect Dis (2012) 2.45
Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis (2012) 2.39
Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection. AIDS (2010) 2.22
Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J (2005) 2.21
Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women. J Infect Dis (2013) 2.15
Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers and nondrinkers. Am J Cardiol (1990) 1.90
Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events. Blood (1998) 1.83
HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis (2012) 1.83
Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy. AIDS (2010) 1.79
Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals. HIV Med (2013) 1.56
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study. HIV Med (2006) 1.38
Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin Exp Immunol (1994) 1.35
Cardiovascular risk-factor knowledge and risk perception among HIV-infected adults. J Assoc Nurses AIDS Care (2013) 1.34
Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women. PLoS One (2013) 1.24
Change in alcohol consumption and risk of death from all causes and from ischaemic heart disease. BMJ (1991) 1.20
Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort. AIDS (2014) 1.19
Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort. Circulation (2001) 1.18
Excess mortality among HIV-infected patients diagnosed with substance use dependence or abuse receiving care in a fully integrated medical care program. Alcohol Clin Exp Res (2010) 1.13
The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study). Am J Epidemiol (2008) 1.10
Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adults. Arterioscler Thromb Vasc Biol (2012) 1.08
Long-term suppressive combined antiretroviral treatment does not normalize the serum level of soluble CD14. J Infect Dis (2013) 1.01
Interleukin-6 and d-dimer levels are associated with vascular dysfunction in patients with untreated HIV infection. HIV Med (2010) 1.00
Immune activation in HIV-infected aging women on antiretrovirals--implications for age-associated comorbidities: a cross-sectional pilot study. PLoS One (2013) 0.96
Lipopolysaccharide-binding protein and CD14 are increased in the bronchoalveolar lavage fluid of smokers. Eur Respir J (2008) 0.95
Relationship between microbial translocation and endothelial function in HIV infected patients. PLoS One (2012) 0.91
Managing tobacco use: the neglected cardiovascular disease risk factor. Eur Heart J (2013) 0.91
Circulating endothelial-coagulative activation markers after smoking cessation: a 12-month observational study. Eur J Clin Invest (2010) 0.89
Acute myocardial infarction: association with time since stopping smoking in Italy. GISSI-EFRIM Investigators. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto. Epidemiologia dei Fattori di Rischio dell'Infarto Miocardico. J Epidemiol Community Health (1994) 0.86
Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progression. Clin Infect Dis (2012) 0.85
Factors associated with D-dimer levels in HIV-infected individuals. PLoS One (2014) 0.84
Lifestyle factors and coagulation activation markers: the Caerphilly Study. Blood Coagul Fibrinolysis (2001) 0.83
Markers of microbial translocation predict hypertension in HIV-infected individuals. HIV Med (2013) 0.82
Regular alcohol intake and fibrinolysis. Neth J Med (2002) 0.78
The effect of ethanol and its metabolism on fibrinolysis. Thromb Haemost (2010) 0.77
Evaluation of a behavioral measure of risk taking: the Balloon Analogue Risk Task (BART). J Exp Psychol Appl (2002) 7.26
Distress tolerance and duration of past smoking cessation attempts. J Abnorm Psychol (2002) 4.52
Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS (2004) 4.17
Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. J Am Acad Dermatol (2011) 3.11
Development and preliminary validation of the young adult alcohol consequences questionnaire. J Stud Alcohol (2006) 3.11
Examining the role of drinking motives in college student alcohol use and problems. Psychol Addict Behav (2003) 2.72
The Balloon Analogue Risk Task (BART) differentiates smokers and nonsmokers. Exp Clin Psychopharmacol (2003) 2.66
Distress tolerance and early smoking lapse. Clin Psychol Rev (2005) 2.61
Substance abuse and relationship violence among men court-referred to batterers' intervention programs. Subst Abus (2003) 2.39
Validation of the timeline follow-back in the assessment of adolescent smoking. Drug Alcohol Depend (2005) 2.37
Drinking before drinking: pregaming and drinking games in mandated students. Addict Behav (2007) 2.14
Dimensions of depressive symptoms and smoking cessation. Nicotine Tob Res (2008) 2.06
Substance use and posttraumatic stress disorders: symptom interplay and effects on outcome. Addict Behav (2004) 2.02
Self-efficacy and smoking cessation: a meta-analysis. Psychol Addict Behav (2009) 2.01
Delayed reward discounting predicts treatment response for heavy drinkers receiving smoking cessation treatment. Drug Alcohol Depend (2009) 2.01
Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis (2011) 2.00
Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis (2013) 1.94
Distress tolerance as a predictor of early treatment dropout in a residential substance abuse treatment facility. J Abnorm Psychol (2005) 1.94
A prospective examination of distress tolerance and early smoking lapse in adult self-quitters. Nicotine Tob Res (2009) 1.87
Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med (2015) 1.86
HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis (2012) 1.83
Hazardous drinking and relationship violence perpetration and victimization in women arrested for domestic violence. J Stud Alcohol (2004) 1.80
Investigation of false positive results with an oral fluid rapid HIV-1/2 antibody test. PLoS One (2007) 1.80
Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999-2006. J Am Acad Dermatol (2011) 1.76
Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms. J Consult Clin Psychol (2010) 1.73
Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine. J Infect Dis (2005) 1.72
Distress tolerance treatment for early-lapse smokers: rationale, program description, and preliminary findings. Behav Modif (2008) 1.71
Randomized clinical trial examining the incremental efficacy of a 90-minute motivational alcohol intervention as an adjunct to standard batterer intervention for men. Addiction (2013) 1.68
Motivational interventions for heavy drinking college students: examining the role of discrepancy-related psychological processes. Psychol Addict Behav (2005) 1.66
Changes in sensation seeking and risk-taking propensity predict increases in alcohol use among early adolescents. Alcohol Clin Exp Res (2010) 1.60
High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy. Clin Infect Dis (2010) 1.58
Stepped care for mandated college students: a pilot study. Am J Addict (2007) 1.58
Social recovery model: an 8-year investigation of adolescent 12-step group involvement following inpatient treatment. Alcohol Clin Exp Res (2008) 1.57
Evaluation of the continuum of gambling problems using the DSM-IV. Addiction (2007) 1.54
Patterns of change in depressive symptoms during smoking cessation: who's at risk for relapse? J Consult Clin Psychol (2002) 1.54
Psychiatric disorders, familial factors, and cigarette smoking: II. Associations with progression to daily smoking. Nicotine Tob Res (2004) 1.53
Psychological distress tolerance and duration of most recent abstinence attempt among residential treatment-seeking substance abusers. Psychol Addict Behav (2005) 1.52
Nonclinical panic attack history and smoking cessation: an initial examination. Addict Behav (2004) 1.52
Latent structure of facets of alcohol reinforcement from a behavioral economic demand curve. Psychopharmacology (Berl) (2008) 1.50
Distress tolerance and early adolescent externalizing and internalizing symptoms: the moderating role of gender and ethnicity. Behav Res Ther (2008) 1.49
Cigarette smoking and substance use among men court-referred to domestic violence treatment programs. Am J Addict (2004) 1.46
Psychiatric disorders, familial factors and cigarette smoking: I. Associations with smoking initiation. Nicotine Tob Res (2003) 1.45
A randomized controlled trial of goal choice interventions for alcohol use disorders among men who have sex with men. J Consult Clin Psychol (2007) 1.44
Predicting functional outcomes among college drinkers: reliability and predictive validity of the Young Adult Alcohol Consequences Questionnaire. Addict Behav (2007) 1.44
Reasons for intimate partner violence perpetration among arrested women. Violence Against Women (2006) 1.37
Addressing alcohol use and problems in mandated college students: a randomized clinical trial using stepped care. J Consult Clin Psychol (2012) 1.36
Bupropion and cognitive-behavioral treatment for depression in smoking cessation. Nicotine Tob Res (2007) 1.34
Can 12-step group participation strengthen and extend the benefits of adolescent addiction treatment? A prospective analysis. Drug Alcohol Depend (2010) 1.33
Impact of bupropion and cognitive-behavioral treatment for depression on positive affect, negative affect, and urges to smoke during cessation treatment. Nicotine Tob Res (2009) 1.29
Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. Nicotine Tob Res (2007) 1.26
Aerobic exercise for alcohol recovery: rationale, program description, and preliminary findings. Behav Modif (2008) 1.26
Linking measures of adolescent nicotine dependence to a common latent continuum. Drug Alcohol Depend (2008) 1.25
Profiles of college students mandated to alcohol intervention. J Stud Alcohol Drugs (2008) 1.25
Relations between anhedonia and smoking motivation. Nicotine Tob Res (2009) 1.24
Ongoing sexually transmitted disease acquisition and risk-taking behavior among US HIV-infected patients in primary care: implications for prevention interventions. Sex Transm Dis (2012) 1.23
The role of negative affect in risk for early lapse among low distress tolerance smokers. Addict Behav (2008) 1.23
Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US. Antivir Ther (2012) 1.22
Treatment of co-occurring substance abuse and suicidality among adolescents: a randomized trial. J Consult Clin Psychol (2011) 1.22
Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study). Sex Transm Dis (2011) 1.21
Development and validation of an adolescent smoking consequences questionnaire. Nicotine Tob Res (2005) 1.21
Balanced placebo design with marijuana: pharmacological and expectancy effects on impulsivity and risk taking. Psychopharmacology (Berl) (2012) 1.21
Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder. Am J Addict (2008) 1.20
Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006. J Am Acad Dermatol (2011) 1.20
Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort. AIDS (2014) 1.19
Progression of carotid intima-media thickness in a contemporary human immunodeficiency virus cohort. Clin Infect Dis (2011) 1.18
Alcoholics anonymous and relapse prevention as maintenance strategies after conjoint behavioral alcohol treatment for men: 18-month outcomes. J Consult Clin Psychol (2004) 1.18
Ecological momentary assessment of adolescent smoking cessation: a feasibility study. Nicotine Tob Res (2008) 1.18
Nicotine dependence symptoms among adolescents with psychiatric disorders: using a Rasch model to evaluate symptom expression across time. Nicotine Tob Res (2007) 1.15
Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay. J Clin Virol (2011) 1.15
HIV-1 RNA rectal shedding is reduced in men with low plasma HIV-1 RNA viral loads and is not enhanced by sexually transmitted bacterial infections of the rectum. J Infect Dis (2011) 1.15
Relationship aggression and substance use among women court-referred to domestic violence intervention programs. Addict Behav (2003) 1.15
Impulsivity-like traits and smoking behavior in college students. Addict Behav (2010) 1.14
A randomized clinical trial of naltrexone and behavioral therapy for problem drinking men who have sex with men. J Consult Clin Psychol (2012) 1.13
A Pilot Study of Aerobic Exercise as an Adjunctive Treatment for Drug Dependence. Ment Health Phys Act (2010) 1.13
Reductions in marital violence following treatment for alcohol dependence. J Interpers Violence (2003) 1.13
The factor structure and severity of DSM-IV alcohol abuse and dependence symptoms in psychiatric outpatients. J Stud Alcohol Drugs (2008) 1.13
Emotional responding to biological challenge as a function of panic disorder and smoking. J Anxiety Disord (2004) 1.11
Finding order in the DSM-IV nicotine dependence syndrome: a Rasch analysis. Drug Alcohol Depend (2003) 1.11
Daily college student drinking patterns across the first year of college. J Stud Alcohol Drugs (2012) 1.10
The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study). Am J Epidemiol (2008) 1.10
Evaluating the role of panic disorder in emotional sensitivity processes involved with smoking. J Anxiety Disord (2005) 1.09
Acute Effects of Marijuana Smoking on Negative and Positive Affect. J Cogn Psychother (2011) 1.08
Psychopathology in women arrested for domestic violence. J Interpers Violence (2006) 1.06
Factors associated with non-adherence to antiretroviral therapy in the SUN study. AIDS Care (2011) 1.06
Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana. Exp Clin Psychopharmacol (2009) 1.05
Development and preliminary randomized controlled trial of a distress tolerance treatment for smokers with a history of early lapse. Nicotine Tob Res (2013) 1.04
Prevalence and risk factors associated with herpes simplex virus-2 infection in a contemporary cohort of HIV-infected persons in the United States. Sex Transm Dis (2012) 1.03
Contingency management and motivational enhancement: a randomized clinical trial for college student smokers. Nicotine Tob Res (2009) 1.01
Serostatus disclosure among adults with HIV in the era of HIV therapy. AIDS Patient Care STDS (2011) 1.01
Nicotine withdrawal among adolescents with acute psychopathology: an item response analysis. Nicotine Tob Res (2004) 1.01
Twelve-week outcomes from an investigation of high-dose nicotine patch therapy for heavy smokers with a past history of alcohol dependence. Psychol Addict Behav (2004) 1.00